A61K 45/06
Mixtures of active ingredients without chemical characterisation
Official title: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A61K45/06 (Mixtures of active ingredients without chemical characterisation) appears on 40,819 US grants and 79,737 published applications in this corpus.
Search patents in A61K- Granted patents
- 40,819
- Published applications
- 79,737
- Assignees
- 16,841
- Inventors
- 100,759
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 3 | 0 |
| 1978 | 3 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 6 | 0 |
| 1983 | 2 | 0 |
| 1984 | 12 | 0 |
| 1985 | 7 | 0 |
| 1986 | 8 | 0 |
| 1987 | 8 | 0 |
| 1988 | 20 | 0 |
| 1989 | 24 | 0 |
| 1990 | 18 | 0 |
| 1991 | 18 | 0 |
| 1992 | 14 | 0 |
| 1993 | 35 | 0 |
| 1994 | 44 | 0 |
| 1995 | 64 | 0 |
| 1996 | 129 | 0 |
| 1997 | 233 | 0 |
| 1998 | 248 | 0 |
| 1999 | 268 | 0 |
| 2000 | 302 | 0 |
| 2001 | 426 | 206 |
| 2002 | 483 | 845 |
| 2003 | 483 | 1245 |
| 2004 | 324 | 1507 |
| 2005 | 335 | 1619 |
| 2006 | 395 | 1498 |
| 2007 | 347 | 1515 |
| 2008 | 331 | 1596 |
| 2009 | 413 | 1838 |
| 2010 | 677 | 2291 |
| 2011 | 711 | 2357 |
| 2012 | 1053 | 2401 |
| 2013 | 1617 | 3588 |
| 2014 | 2110 | 4554 |
| 2015 | 2439 | 4467 |
| 2016 | 2703 | 4673 |
| 2017 | 2962 | 4524 |
| 2018 | 2815 | 4268 |
| 2019 | 2810 | 4376 |
| 2020 | 2786 | 4960 |
| 2021 | 2570 | 5092 |
| 2022 | 2523 | 4858 |
| 2023 | 2166 | 4768 |
| 2024 | 2201 | 4465 |
| 2025 | 2289 | 3726 |
| 2026 | 1378 | 2500 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Hydrogels as oral delivery dosage forms, methods of making and using same6 Oct 2026US 12,751,917 B2VeraMorph LLC
- Parenteral treatments involving aminoadamantane derivatives6 Oct 2026US 12,751,934 B2Shinkei Therapeutics, Inc.
- Dosage forms for TYK2 inhibitors6 Oct 2026US 12,751,948 B2Bristol-Myers Squibb Company
- CDK inhibitors6 Oct 2026US 12,751,951 B2Genentech, Inc.
- Anti-Claudin18.2 antigen-binding fragment or antibody, and use thereof182551196 Oct 2026US 12,751,972 B2Guangzhou Bio-Gene Technology Co., Ltd
- Tea compositions comprising paraxanthine and methods of production thereof8 Oct 2026US 2026/0305643 A1
- Interface structure for a bioelectrode8 Oct 2026US 2026/0306000 A1Teknologian tutkimuskeskus VTT Oy
- Aqueous formulations comprising fullerene, structured water, dissolved hydrogen gas, minerals and additives8 Oct 2026US 2026/0306402 A1Best Planet Science LLC
- Liposome compositions and medical uses thereof8 Oct 2026US 2026/0306404 A1
- Sulfurized imidazoles in ophthalmic formulations8 Oct 2026US 2026/0306431 A1Geneiii Biotech Company Ltd.
Most cited
By later US patents
- Retrograde tissue splitter and method1,605US 5,449,355 AValleylab, Inc. · 1995
- Retrograde tissue splitter and method1,585US 5,797,906 AValleylab, Inc. · 1998
- Method of treating androgen independent prostate cancer1,091US 9,040,574 B2Natrogen Therapeutics International, Inc. · 2015
- Anti-angiogenic compositions and methods of use968US 5,716,981 AAngiogenesis Technologies, Inc. · 1998
- Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation733US 9,101,621 B2Celgene Corporation · 2015